✦ LIBER ✦

A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetes

✍ Scribed by T. Soulis; S. Sastra; V. Thallas; S. B. Mortensen; M. Wilken; J. T. Clausen; O. J. Bjerrum; H. Petersen; J. Lau; G. Jerums; E. Boel; M. E. Cooper

Publisher: Springer
Year: 1999
Tongue: English
Weight: 249 KB
Volume: 42
Category: Article
ISSN: 0012-186X
DOI: 10.1007/s001250051181

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Suppression of transforming growth facto

Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195

✍ K. Tsuchida; Z. Makita; S. Yamagishi; T. Atsumi; H. Miyoshi; S. Obara; M. Ishida 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 697 KB

Glyceraldehyde-derived advanced glycatio

Glyceraldehyde-derived advanced glycation end products (AGEs). A novel biomarker of postprandial hyperglycaemia in diabetic rats

✍ Y. Kitahara; M. Takeuchi; K. Miura; T. Mine; T. Matsui; S. Yamagishi 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 83 KB

ChemInform Abstract: Flavan-3-ols Having

ChemInform Abstract: Flavan-3-ols Having a γ-Lactam from the Roots of Actinidia arguta Inhibit the Formation of Advanced Glycation End Products in vitro

✍ Dae Sik Jang; Ga Young Lee; Yun Mi Lee; Young Sook Kim; Hang Sun; Dong-Hee Kim; 📂 Article 📅 2009 🏛 John Wiley and Sons ⚖ 20 KB 👁 1 views